लोड हो रहा है...

Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™

Aplidin™ (APL) is a new antitumoral drug from marine origin currently in phase II clinical trials against a wide multiplicity of cancers. As resistance may be, as with other drugs, an important obstacle to the APL therapeutic efficacy, we have established an acquired resistance cellular model by con...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Losada, A, López-Oliva, J M, Sánchez-Puelles, J M, García-Fernández, L F
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2004
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409906/
https://ncbi.nlm.nih.gov/pubmed/15365569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602166
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!